ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

Sodium hydride → 4-[4-(4-Methanesulfonyl-phenoxy)-pyrazolo[3,4-d]pyrimidin-1-yl]-piperidine-1-carboxylic acid tert-butyl ester

HRID 1931666
印刷

反応式

HRID 1931666 の反応式
[H-].[Na+].[CH3:3][S:4]([C:7]1[CH:12]=[CH:11][C:10]([OH:13])=[CH:9][CH:8]=1)(=[O:6])=[O:5].[C:14]([O:18][C:19]([N:21]1[CH2:26][CH2:25][CH:24]([N:27]2[C:31]3=[N:32][CH:33]=[N:34][C:35](Cl)=[C:30]3[CH:29]=[N:28]2)[CH2:23][CH2:22]1)=[O:20])([CH3:17])([CH3:16])[CH3:15].[Cl-].[NH4+]>CN(C)C=O>[C:14]([O:18][C:19]([N:21]1[CH2:22][CH2:23][CH:24]([N:27]2[C:31]3=[N:32][CH:33]=[N:34][C:35]([O:13][C:10]4[CH:11]=[CH:12][C:7]([S:4]([CH3:3])(=[O:5])=[O:6])=[CH:8][CH:9]=4)=[C:30]3[CH:29]=[N:28]2)[CH2:25][CH2:26]1)=[O:20])([CH3:17])([CH3:15])[CH3:16]
参加物実験手順後処理出典と根拠反応ノート

参加物

6

反応物 4

HCID 24758Sodium hydrideHCID 25517Ammonium ChlorideHCID 1233504-(Methylsulfonyl)phenolHCID 57964905Tert-butyl 4-(4-chloro-1H-pyrazolo[3,4-D]pyrimidin-1-YL)piperidine-1-carboxylate2 回

生成物 1

HCID 532576834-[4-(4-Methanesulfonyl-phenoxy)-pyrazolo[3,4-d]pyrimidin-1-yl]-piperidine-1-carboxylic acid tert-butyl ester収率 52.8%

試薬・触媒・溶媒 1

HCID 6228Dimethylformamide溶媒2 回

実験手順

Sodium hydride (60% dispersion in mineral oil; 82 mg, 2.1 mmol) was added to a solution of 4-(methylsulfonyl)phenol (281 mg, 1.6 mmol) in dimethylformamide (9 mL) and the mixture was stirred at room temperature for 20 min. A solution of 4-(4-chloro-pyrazolo[3,4-d]pyrimidin-1-yl)piperidine-1-carboxylic acid tert-butyl ester (Intermediate 19; 551 mg, 1.6 mmol) in dimethylformamide (5 mL) was added, and the reaction mixture was stirred at room temperature for 3.5 h. Saturated aqueous ammonium chloride solution was added and the mixture was extracted with ethyl acetate (3×90 mL). The organic layer was washed with water (3 times) and brine, dried (sodium sulfate), filtered, evaporated and purified on a flash silica column (40 mm×4″) eluting with 66-75% ethyl acetate/hexanes to give 4-[4-(4-methanesulfonyl-phenoxy)-pyrazolo[3,4-d]pyrimidin-1-yl]-piperidine-1-carboxylic acid tert-butyl ester (400 mg, 52%) as a white solid. 1H NMR (300 MHz, DMSO-d6) δ 1.41 (s, 9H), 1.92-2.02 (m, 4H), 2.94-3.05 (m, 2H), 3.28-3.30 (m, methyl sulfone and water peak), 4.04-4.12 (m, 2H), 4.94-5.06 (m, 1H), 7.59-7.64 (m, 2H), 8.01-8.06 (m, 2H), 8.37 (s, 1H), 8.54 (s, 1H). Mass spectrum (ES) MH+=474.

後処理

  1. stirringthe reaction mixture was stirred at room temperature for 3.5 h
  2. extractionthe mixture was extracted with ethyl acetate (3×90 mL)
  3. washThe organic layer was washed with water (3 times) and brine
  4. dry with materialdried (sodium sulfate)
  5. filtrationfiltered
  6. customevaporated
  7. custompurified on a flash silica column (40 mm×4″)
  8. washeluting with 66-75% ethyl acetate/hexanes

出典と根拠

ORDレコード
ord-740e5c5c830e4288903738142fcb1776
出典データセット
uspto-grants-2012_05
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US08188098B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート